APA (7th ed.) Citation

Dossier, C., Prim, B., Moreau, C., Kwon, T., Maisin, A., Nathanson, S., . . . Deschênes, G. (2021). A global antiB cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome. Pediatric Nephrology, 36(5), 1175. https://doi.org/10.1007/s00467-020-04811-0

Chicago Style (17th ed.) Citation

Dossier, Claire, et al. "A Global AntiB Cell Strategy Combining Obinutuzumab and Daratumumab in Severe Pediatric Nephrotic Syndrome." Pediatric Nephrology 36, no. 5 (2021): 1175. https://doi.org/10.1007/s00467-020-04811-0.

MLA (9th ed.) Citation

Dossier, Claire, et al. "A Global AntiB Cell Strategy Combining Obinutuzumab and Daratumumab in Severe Pediatric Nephrotic Syndrome." Pediatric Nephrology, vol. 36, no. 5, 2021, p. 1175, https://doi.org/10.1007/s00467-020-04811-0.